Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion type Assertion NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_head.
- NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion description "[As part of our HPV-PathogenISS study, a series of 150 squamous cell carcinomas (SCC) and 152 CIN lesions were examined using immunohistochemical (IHC) staining for topoisomerase IIalpha (topo IIalpha), and tested for HPV using PCR with three primer sets (MY09/11, GP5/GP6, SPF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_provenance.
- NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion evidence source_evidence_literature NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_provenance.
- NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion SIO_000772 16990717 NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_provenance.
- NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion wasDerivedFrom befree-2016 NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_provenance.
- NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_assertion wasGeneratedBy ECO_0000203 NP570553.RAn6hog6Amu6wGezAOIf_LO7vlql0MiqLELjgwl9bqPVE130_provenance.